These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 21243491
1. Leflunomide use in a cytomegalovirus infection of a patient with dermatomyositis. Orden AO, Chuluyan JC, Colombini AC, Barbera RF. Rheumatol Int; 2012 Jan; 32(1):273-5. PubMed ID: 21243491 [Abstract] [Full Text] [Related]
2. Cytomegalovirus-induced interstitial pneumonitis in a patient with dermatomyositis. Kaşifoğlu T, Korkmaz C, Ozkan R. Clin Rheumatol; 2006 Sep; 25(5):731-3. PubMed ID: 16267608 [Abstract] [Full Text] [Related]
3. Can leflunomide play a role in cytomegalovirus disease prophylaxis besides its antirheumatic effects? Lu CH, Tsai JH, Wu MZ, Yu CL, Hsieh SC. Antivir Ther; 2015 Sep; 20(1):93-6. PubMed ID: 24831792 [Abstract] [Full Text] [Related]
5. Treatment of refractory CMV-infection following hematopoietic stem cell transplantation with the combination of foscarnet and leflunomide. Ehlert K, Groll AH, Kuehn J, Vormoor J. Klin Padiatr; 2006 Sep; 218(3):180-4. PubMed ID: 16688677 [Abstract] [Full Text] [Related]
6. Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide. Waldman WJ, Knight DA, Lurain NS, Miller DM, Sedmak DD, Williams JW, Chong AS. Transplantation; 1999 Sep 27; 68(6):814-25. PubMed ID: 10515382 [Abstract] [Full Text] [Related]
7. Leflunomide for cytomegalovirus: bench to bedside. Chacko B, John GT. Transpl Infect Dis; 2012 Apr 27; 14(2):111-20. PubMed ID: 22093814 [Abstract] [Full Text] [Related]
8. Leflunomide as a rescue treatment in ganciclovir-resistant cytomegalovirus infection in a seronegative renal transplant recipient--a case report. Ciszek M, Mucha K, Foroncewicz B, Chmura A, Pączek L. Ann Transplant; 2014 Jan 30; 19():60-3. PubMed ID: 24481271 [Abstract] [Full Text] [Related]
9. Concurrent antiviral and immunosuppressive activities of leflunomide in vivo. Chong AS, Zeng H, Knight DA, Shen J, Meister GT, Williams JW, Waldman WJ. Am J Transplant; 2006 Jan 30; 6(1):69-75. PubMed ID: 16433758 [Abstract] [Full Text] [Related]
10. [Management of cytomegalovirus infections in patients treated with immunosuppressive drugs for chronic inflammatory diseases]. Tnani N, Massoumi A, Lortholary O, Soussan P, Prinseau J, Baglin A, Hanslik T. Rev Med Interne; 2008 Apr 30; 29(4):305-10. PubMed ID: 18068874 [Abstract] [Full Text] [Related]
11. Cytomegalovirus infection in organ transplant recipients. Hibberd PL, Snydman DR. Infect Dis Clin North Am; 1995 Dec 30; 9(4):863-77. PubMed ID: 8747770 [Abstract] [Full Text] [Related]
12. Treatment of multidrug-resistant cytomegalovirus retinitis with systemically administered leflunomide. Levi ME, Mandava N, Chan LK, Weinberg A, Olson JL. Transpl Infect Dis; 2006 Mar 30; 8(1):38-43. PubMed ID: 16623819 [Abstract] [Full Text] [Related]
13. Leflunomide: a possible alternative for gangciclovir sensitive and resistant cytomegalovirus infections. Sudarsanam TD, Sahni RD, John GT. Postgrad Med J; 2006 May 30; 82(967):313-4. PubMed ID: 16679469 [Abstract] [Full Text] [Related]
14. Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Waldman WJ, Knight DA, Blinder L, Shen J, Lurain NS, Miller DM, Sedmak DD, Williams JW, Chong AS. Intervirology; 1999 May 30; 42(5-6):412-8. PubMed ID: 10702725 [Abstract] [Full Text] [Related]
15. Leflunomide as part of the treatment for multidrug-resistant cytomegalovirus disease after lung transplantation: case report and review of the literature. Verkaik NJ, Hoek RA, van Bergeijk H, van Hal PT, Schipper ME, Pas SD, Beersma MF, Boucher CA, Jedema I, Falkenburg F, Hoogsteden HC, van den Blink B, Murk JL. Transpl Infect Dis; 2013 Dec 30; 15(6):E243-9. PubMed ID: 24298985 [Abstract] [Full Text] [Related]
16. Utility of leflunomide in the treatment of complex cytomegalovirus syndromes. Avery RK, Mossad SB, Poggio E, Lard M, Budev M, Bolwell B, Waldman WJ, Braun W, Mawhorter SD, Fatica R, Krishnamurthi V, Young JB, Shrestha R, Stephany B, Lurain N, Yen-Lieberman B. Transplantation; 2010 Aug 27; 90(4):419-26. PubMed ID: 20683281 [Abstract] [Full Text] [Related]
17. Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection. Avery RK, Bolwell BJ, Yen-Lieberman B, Lurain N, Waldman WJ, Longworth DL, Taege AJ, Mossad SB, Kohn D, Long JR, Curtis J, Kalaycio M, Pohlman B, Williams JW. Bone Marrow Transplant; 2004 Dec 27; 34(12):1071-5. PubMed ID: 15489872 [Abstract] [Full Text] [Related]
18. The use of sirolimus in patients with recurrent cytomegalovirus infection after kidney transplantation: A retrospective case series analysis. Shendi AM, Hung RKY, Caplin B, Griffiths P, Harber M. Saudi J Kidney Dis Transpl; 2019 Dec 27; 30(3):606-614. PubMed ID: 31249224 [Abstract] [Full Text] [Related]
19. Cytomegalovirus and ulcerative colitis: Place of antiviral therapy. Pillet S, Pozzetto B, Roblin X. World J Gastroenterol; 2016 Feb 14; 22(6):2030-45. PubMed ID: 26877608 [Abstract] [Full Text] [Related]
20. Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients: A case series. El Chaer F, Mori N, Shah D, Oliver N, Wang E, Jan A, Doan V, Tverdek F, Tayar J, Ariza-Heredia E, Chemaly RF. Antiviral Res; 2016 Nov 14; 135():91-96. PubMed ID: 27594527 [Abstract] [Full Text] [Related] Page: [Next] [New Search]